Marwaha Sagar, Agarwal Rachna, Tripathi Manjari, Tripathi Shashank
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Department of Neurochemistry, Institute of Human Behavior and Allied Sciences, New Delhi, India.
J Hum Nutr Diet. 2025 Feb;38(1):e70007. doi: 10.1111/jhn.70007.
The progression of Alzheimer's disease (AD) is intricately tied to the impairment of neurons, crucial for neurological functions. Despite extensive research, the precise mechanism underlying AD development remains elusive due to its multifaceted aetiology. Vitamin deficiency has emerged as a notable contributor to AD onset and progression, exerting a significant influence on brain function. To explore this link, we conducted a thorough review using PubMed, Web of Science and MEDLINE databases to gather literature on average vitamin concentrations in people with AD and healthy controls. Applying frequentist network meta-analysis techniques, we calculated standardised mean differences (SMDs) in vitamin concentrations between AD and control groups, both directly and indirectly. Our analysis, based on 67 articles, revealed statistically significant findings for various vitamins. Notably, vitamin C displayed the most substantial difference in average concentration between AD and control groups, supported by a high p-score of 0.92. Other vitamins that showed significant differences included vitamin D, folate, vitamin E, vitamin A and vitamin B12. Moreover, by considering alternative reference groups of vitamins, we derived indirect estimates, which further emphasised the role of vitamins in AD pathology. The ranking of vitamins based on their discrepancy in concentration between AD and control groups underscored the importance of vitamin C, followed by vitamin D, vitamin E, folate, vitamin A and vitamin B12. In conclusion, our comprehensive analysis highlights the potential significance of vitamin levels in understanding AD pathology. This underscores avenues for further research and potential therapeutic interventions targeting vitamin deficiencies in people with AD, potentially offering new strategies for managing the disease. Trial Registration: CRD42023447203.
阿尔茨海默病(AD)的进展与对神经功能至关重要的神经元损伤密切相关。尽管进行了广泛研究,但由于其病因多方面,AD发展的精确机制仍不清楚。维生素缺乏已成为AD发病和进展的一个显著因素,对脑功能有重大影响。为了探究这种联系,我们使用PubMed、科学网和医学在线数据库进行了全面综述,以收集有关AD患者和健康对照者平均维生素浓度的文献。应用频率学派网络荟萃分析技术,我们直接和间接地计算了AD组和对照组之间维生素浓度的标准化平均差异(SMD)。我们基于67篇文章的分析揭示了各种维生素具有统计学意义的结果。值得注意的是,维生素C在AD组和对照组之间的平均浓度差异最为显著,其p值高达0.92。其他显示出显著差异的维生素包括维生素D、叶酸、维生素E、维生素A和维生素B12。此外,通过考虑维生素的替代参照组,我们得出了间接估计值,这进一步强调了维生素在AD病理中的作用。根据AD组和对照组之间浓度差异对维生素进行的排名突出了维生素C的重要性,其次是维生素D、维生素E、叶酸、维生素A和维生素B12。总之,我们的综合分析突出了维生素水平在理解AD病理方面的潜在重要性。这强调了进一步研究的途径以及针对AD患者维生素缺乏的潜在治疗干预措施,可能为管理该疾病提供新策略。试验注册号:CRD42023447203。